Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

The discovery of susceptibility genes for mental disorders.

Cloninger CR.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13365-7. Epub 2002 Oct 8. Review. No abstract available.

2.

The N-methyl-D-aspartate receptor and schizophrenia.

Strous RD, Javitt DC.

Isr J Med Sci. 1996 May;32(5):275-81. Review. No abstract available.

PMID:
8641863
3.

[Mutant mouse lacking D-amino-acid oxidase activity].

Konno R.

Seikagaku. 2008 Apr;80(4):337-43. Review. Japanese. No abstract available.

PMID:
18516913
4.

D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.

Yamanaka M, Miyoshi Y, Ohide H, Hamase K, Konno R.

Amino Acids. 2012 Nov;43(5):1811-21. doi: 10.1007/s00726-012-1384-x. Epub 2012 Aug 15. Review.

PMID:
22892863
5.

Glutamatergic animal models of schizophrenia.

Moghaddam B, Jackson ME.

Ann N Y Acad Sci. 2003 Nov;1003:131-7. Review.

PMID:
14684441
6.

Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia.

Boks MP, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ, Kahn RS.

Eur Neuropsychopharmacol. 2007 Sep;17(9):567-72. Epub 2007 Jan 23. Review.

PMID:
17250995
7.

NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia.

Coyle JT, Tsai G.

Int Rev Neurobiol. 2004;59:491-515. Review. No abstract available.

PMID:
15006500
8.

[Biological basis for schizophrenia].

Kato K.

Seishin Shinkeigaku Zasshi. 2010;112(4):390-5. Review. Japanese. No abstract available.

PMID:
20556898
9.

[Schizophrenia and glutamate transport systems].

Nishikawa T.

Seishin Shinkeigaku Zasshi. 2009;111(7):859-67. Review. Japanese. No abstract available.

PMID:
19999298
10.
11.

Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.

Gaspar PA, Bustamante ML, Silva H, Aboitiz F.

J Neurochem. 2009 Nov;111(4):891-900. doi: 10.1111/j.1471-4159.2009.06325.x. Epub 2009 Aug 4. Review.

12.

Genomic imprinting and fragile X-syndrome in psychiatric disorders.

Grigoroiu-Serb─ânescu M.

Rom J Neurol Psychiatry. 1993 Jan-Mar;31(1):3-10. Review. No abstract available.

PMID:
8363976
13.
14.

The role of DNA copy number variation in schizophrenia.

Tam GW, Redon R, Carter NP, Grant SG.

Biol Psychiatry. 2009 Dec 1;66(11):1005-12. doi: 10.1016/j.biopsych.2009.07.027. Epub 2009 Sep 12. Review.

PMID:
19748074
16.

Mutant mice and rats lacking D-amino acid oxidase.

Konno R, Hamase K, Maruyama R, Zaitsu K.

Chem Biodivers. 2010 Jun;7(6):1450-8. doi: 10.1002/cbdv.200900303. Review.

PMID:
20564563
17.

Recent advances in the genetics of schizophrenia.

O'Donovan MC, Williams NM, Owen MJ.

Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R125-33. Epub 2003 Sep 2. Review.

PMID:
12952866
18.

Where do you think you are going? The NMDA-D1 receptor trap.

Cepeda C, Levine MS.

Sci STKE. 2006 May 2;2006(333):pe20. Review.

PMID:
16670371
19.

[Search for early prognostic factors in schizophrenia: current problems (review of the literature)].

Koloskova MV, Bazhenova OV.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(9):120-5. Review. Russian. No abstract available.

PMID:
2176028
20.

Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia.

Phillips WA, Silverstein SM.

Behav Brain Sci. 2003 Feb;26(1):65-82; discussion 82-137. Review.

PMID:
14598440

Supplemental Content

Support Center